Christiane R Querfeld

Trials

Studies that name Christiane R Querfeld as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:56 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT04930653 · Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

  City of Hope Medical Center · recruiting · Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 03:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Cutaneous T cell lymphoma: a paradigm for dissecting susceptibility and resistance to checkpoint inhibition therapy
  R01CA229510 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2019 to 2023 · $552,383 awarded in 2023
  Same name and institution; not confirmed by an ID
• Genomic Analysis of Cutaneous CD30+ Lymphoproliferative Disorders
  R21CA259932 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · fiscal years 2022 to 2023 · $215,936 awarded in 2023
  Same name and institution; not confirmed by an ID

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Leadership, Planning and Evaluation
  P30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2004 to 2026
  Named on NCT04930653